[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

UA41989C2 - Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри - Google Patents

Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри

Info

Publication number
UA41989C2
UA41989C2 UA96103958A UA96103958A UA41989C2 UA 41989 C2 UA41989 C2 UA 41989C2 UA 96103958 A UA96103958 A UA 96103958A UA 96103958 A UA96103958 A UA 96103958A UA 41989 C2 UA41989 C2 UA 41989C2
Authority
UA
Ukraine
Prior art keywords
gel
skin
treating
pharmaceutical composition
skin diseases
Prior art date
Application number
UA96103958A
Other languages
English (en)
Russian (ru)
Inventor
Томсен Йохн Браун
Енс Крістіан Меллер
Энс Кристиан Меллер
Original Assignee
Томсен Йохн Браун
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Томсен Йохн Браун filed Critical Томсен Йохн Браун
Publication of UA41989C2 publication Critical patent/UA41989C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/02—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings containing insect repellants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

Винахід відноситься до невипаровуваного гелю, який утворює матрикс і має адгезивність у відношенні до шкіри, та його застосуванню для локального лікування захворювань шкіри, а також для первинної і вторинної профілактичної обробки ран і для дезинфекції шкіри і т.п. як у людини, так і у тварин. Запропонований гель містить нижчий алканол в концентрації більш ніж 90% і желювальний агент, наприклад етил(гідроксіетил) целюлоза або інший відповідний желювальний агент і можливі добавки. При цьому даний гель може бути використаний для нанесення на шкіру ефективно, легко і без ускладнень. Фармацевтична композиція у вигляді гелю для лікування шкірних захворювань, включає рідину і високомолекулярний полімерний желювальний агент, розчинений в рідині. Композиція містить більш ніж 90 мас.% нижчого алканолу від загальної маси всієї композиції і менш ніж 10 мас.% води від загальної маси композиції.
UA96103958A 1994-03-21 1995-03-20 Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри UA41989C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK32594 1994-03-21
PCT/EP1995/001025 WO1995025544A1 (en) 1994-03-21 1995-03-20 Gel for treatment of skin diseases and for disinfection of the skin

Publications (1)

Publication Number Publication Date
UA41989C2 true UA41989C2 (uk) 2001-10-15

Family

ID=8092278

Family Applications (1)

Application Number Title Priority Date Filing Date
UA96103958A UA41989C2 (uk) 1994-03-21 1995-03-20 Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри

Country Status (26)

Country Link
US (4) US5981605A (uk)
EP (1) EP0751789B1 (uk)
JP (1) JP3560977B2 (uk)
KR (1) KR100396278B1 (uk)
CN (1) CN1146725A (uk)
AT (1) ATE208212T1 (uk)
AU (1) AU701872B2 (uk)
BR (1) BR9507164A (uk)
CA (1) CA2186045A1 (uk)
CZ (2) CZ286758B6 (uk)
DE (1) DE69523745T2 (uk)
DK (1) DK0751789T3 (uk)
EE (1) EE03293B1 (uk)
ES (1) ES2168111T3 (uk)
FI (1) FI963696A (uk)
HU (1) HUP9774641A2 (uk)
LV (1) LV12951B (uk)
MX (1) MX9604208A (uk)
NO (1) NO314126B1 (uk)
NZ (1) NZ283135A (uk)
PL (1) PL179918B1 (uk)
PT (1) PT751789E (uk)
RU (1) RU2142273C1 (uk)
SK (1) SK281575B6 (uk)
UA (1) UA41989C2 (uk)
WO (1) WO1995025544A1 (uk)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2168111T3 (es) * 1994-03-21 2002-06-01 Thomsen Aase Brown Gel para el tratamiento de enfermedades de la piel y para la desinfeccion de la piel.
US6416760B2 (en) * 1995-01-26 2002-07-09 Societe L'oreal Therapeutic/cosmetic compositions comprising CGRP antagonists for treating sensitive human skin
FR2732221B1 (fr) * 1995-03-28 1997-04-25 Oreal Utilisation d'un antagoniste de cgrp pour traiter les rougeurs cutanees d'origine neurogene et composition obtenue
DE19624508A1 (de) * 1996-06-19 1998-01-08 Guetter Hans Peter Dr Verwendung von C¶3¶-C¶4¶-Alkoholen zur Behandlung von Herpeserkrankungen
EP0928187A4 (en) * 1996-06-24 2002-10-02 Bio Safe Entpr Inc ANTIBACTERIAL COMPOSITION
US7767216B2 (en) * 1999-04-28 2010-08-03 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
US6759434B2 (en) 1999-09-22 2004-07-06 B. Ron Johnson Anti-infective compositions, methods and systems for treating disordered tissue
US8173709B2 (en) * 1999-09-22 2012-05-08 Quadex Pharmaceuticals, Llc Anti-infective methods for treating pathogen-induced disordered tissues
WO2001092289A1 (fr) * 2000-05-31 2001-12-06 Japan Science And Technology Corporation Promoteurs de regeneration de tissu cutane contenant le ginsenoside rb1
AUPR028000A0 (en) * 2000-09-21 2000-10-12 Hair Advisory Centre Pty. Ltd. Ectoparasite formulation
US6581775B1 (en) * 2001-08-10 2003-06-24 Garo Hagopian Method of external genital cleansing and prophylactic kit
CA2421026C (en) * 2001-10-16 2005-02-15 Avanir Pharmaceuticals Viral inhibition by n-docosanol
US20050042240A1 (en) * 2002-01-28 2005-02-24 Utterberg David S. High viscosity antibacterials
DE10219597A1 (de) * 2002-05-02 2003-11-20 Wella Ag Wasserfreie Haarstylinggele
JPWO2003105903A1 (ja) * 2002-06-18 2005-10-13 ポーラ化成工業株式会社 抗真菌医薬組成物
US20040191286A1 (en) * 2003-03-24 2004-09-30 Bijan Safai Head lice medication and treatment
GB0318160D0 (en) * 2003-08-02 2003-09-03 Ssl Int Plc Parasiticidal composition
US8741333B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US8741332B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US20070196453A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US20060024372A1 (en) * 2004-07-29 2006-02-02 Utterberg David S High viscosity antibacterials
US7268165B2 (en) * 2004-08-20 2007-09-11 Steris Inc. Enhanced activity alcohol-based antimicrobial compositions
US20070116749A1 (en) * 2005-11-21 2007-05-24 Grossman Leonard D Method for treatment of cellulitis
DE102005059742A1 (de) 2005-12-13 2007-06-14 Beiersdorf Ag Transparentes Sonnenschutzmittel
EP3067044B1 (en) 2006-07-21 2019-03-27 BioDelivery Sciences International, Inc. Transmucosal delivery devices with enhanced uptake
EP2059125B1 (en) 2006-10-23 2013-08-14 Ecolab Inc. Virucidal composition
US20100063004A1 (en) * 2006-12-04 2010-03-11 Ranjan Ray Chaudhuri Topical pharmaceutical composition
JP5028131B2 (ja) * 2007-04-13 2012-09-19 花王株式会社 ゲル化剤
EP2152304B1 (en) 2007-05-02 2018-08-22 The Regents of the University of Michigan Nanoemulsion therapeutic compositions and methods of using the same
US20100247564A1 (en) * 2007-05-24 2010-09-30 David Yue-Wei Lee Methods and compositions for the use of sargassum fusiforme for the inhibition of hiv-1 infection
DE102008028993A1 (de) * 2007-06-29 2009-01-08 Bode Chemie Gmbh & Co. Kg Verwendung eines alkoholischen Desinfektionsmittels zur Schnelldesinfektion
EA013233B1 (ru) * 2008-06-12 2010-04-30 Иностранное Частное Унитарное Производственно-Торговое Предприятие "Инкраслав" Фирмы "Вера, О.О.О. Прешов" Антисептическая композиция для дезинфекции кожных покровов, способ ее приготовления и полупродукт для ее приготовления
US20100158821A1 (en) * 2008-12-22 2010-06-24 Eastman Chemical Company Antimicrobial agents, compositions and products containing the same, and methods of using the compositions and products
US8106111B2 (en) 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
ES2616495T3 (es) * 2009-12-16 2017-06-13 Ecolab Inc. Composición en forma de gel para la desinfección virucida de la piel de mamíferos
US10383894B2 (en) * 2010-03-17 2019-08-20 Lutran Industries, Inc. Human medicinal treatment using salt of peroxymonosulfuric acid
GB201010256D0 (en) * 2010-06-18 2010-07-21 Reckitt Benckiser Inc Germicidal topical compositions
FR2976808B1 (fr) * 2011-06-22 2013-06-28 Urgo Lab Composition filmogene et son utilisation pour le traitement de l'herpes
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US10071233B2 (en) * 2015-05-22 2018-09-11 L'oreal Point applicator for treating skin conditions
US10334853B2 (en) * 2016-03-29 2019-07-02 Larada Sciences Compositions and methods for treating ectoparasite infestation
AU2020372237B2 (en) * 2019-10-25 2024-10-24 Mucocort Ab Treatment of inflammatory condition in mucous membrane or skin

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2054989A (en) * 1933-12-30 1936-09-22 Us Ind Alcohol Co Compositions for application to the human skin
DE1000367B (de) 1952-11-17 1957-01-10 Mo Och Domsjoe Ab Verfahren zur Herstellung von in Wasser und/oder Alkali loeslichen Celluloseaethern
US3016328A (en) * 1961-01-03 1962-01-09 Ethicon Inc Dialdehyde alcoholic sporicidal composition
US4019521A (en) * 1973-06-06 1977-04-26 Philip Morris Incorporated Smokable material and method for preparing same
US3876771A (en) * 1973-09-04 1975-04-08 Hallister Inc Skin protective gel containing polyvinyl methylether or monoisopropyl ester of polyvinyl methylether maleic acid
GB1582744A (en) * 1976-06-04 1981-01-14 Gruenenthal Gmbh 7h-thiazolo (and 1,3,4-thiadiazolo-)(3,2-a) pyrimidin-7-one-5-carboxylic acids derivatives and medicaments therof
SE418686B (sv) * 1978-03-31 1981-06-22 Landstingens Inkopscentral Vattenbaserad salva for huddesinfektion innehallande alkohol som desinfektionsmedel
GB1593097A (en) * 1978-05-26 1981-07-15 Fisons Ltd Pharmaceutical compositions containing a bischromone
US4256872A (en) * 1978-09-26 1981-03-17 Occidental Research Corporation Process for preparing layered organophosphorus inorganic polymers
US4247547A (en) * 1979-03-19 1981-01-27 Johnson & Johnson Tretinoin in a gel vehicle for acne treatment
US4590214A (en) * 1980-04-14 1986-05-20 Sepreh, Inc. Method of treatment for herpes
JPS5855411A (ja) * 1981-09-28 1983-04-01 Nitto Electric Ind Co Ltd 基剤組成物および外用医薬組成物
US4431633A (en) * 1982-04-27 1984-02-14 Merck & Co., Inc. Influenza vaccine
DE3430709A1 (de) * 1984-08-21 1986-03-06 Krüger GmbH & Co KG, 5060 Bergisch Gladbach Viruzides mittel
US5288486A (en) * 1985-10-28 1994-02-22 Calgon Corporation Alcohol-based antimicrobial compositions
US4671955A (en) * 1986-03-31 1987-06-09 Victor Palinczar Waterproof sunscreen compositions
FR2613621B1 (fr) * 1987-04-10 1990-06-29 Roussel Uclaf Butyl hydroxyanisoles pour utilisation dans le traitement prophylactique des maladies a retro-virus comme agents modificateurs de l'infectivite des retro-virus et produits anti-infectants
US5098717A (en) * 1987-12-09 1992-03-24 Thames Pharmacal Co., Inc. Method of treatment for pruritus
US5013545A (en) * 1987-12-09 1991-05-07 Thames Pharmacal Co., Inc. Aqueous gels containing topical medicaments
CA1337329C (en) * 1989-01-31 1995-10-17 Paul L. Simmons Biodegradable disinfectant
US4923875A (en) * 1989-07-10 1990-05-08 Baker Cummins Pharmaceuticals, Inc. Method for treatment of mast cell-mediated dermatologic disorders
US5331012A (en) * 1990-07-30 1994-07-19 Riddick Kenneth B Topical pharmaceutical preparation for fever blisters and other viral infections and method of use
SE9003712L (sv) * 1990-11-22 1992-01-07 Kabi Pharmacia Ab Gelbildande flytande baerarkomposition samt anvaendning daerav i farmaceutiska kompositioner
DK0590024T3 (da) * 1991-06-20 1997-10-20 Viro Tex Corp Topisk præparat, der fremmmer heling af herpeslæsioner
US5376366A (en) 1992-11-12 1994-12-27 John Petchul Composition and process for forming isopropyl alcohol gel with water-soluble vinyl polymer neutralizing agent
ES2168111T3 (es) * 1994-03-21 2002-06-01 Thomsen Aase Brown Gel para el tratamiento de enfermedades de la piel y para la desinfeccion de la piel.
US5665751A (en) * 1995-06-07 1997-09-09 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers

Also Published As

Publication number Publication date
JPH09510468A (ja) 1997-10-21
DE69523745T2 (de) 2002-08-08
US20040054015A1 (en) 2004-03-18
FI963696A (fi) 1996-11-07
HUP9774641A2 (en) 1997-01-28
CZ286758B6 (en) 2000-06-14
PL316651A1 (en) 1997-02-03
WO1995025544A1 (en) 1995-09-28
PT751789E (pt) 2002-04-29
RU2142273C1 (ru) 1999-12-10
CA2186045A1 (en) 1995-09-28
DK0751789T3 (da) 2003-09-08
MX9604208A (es) 1998-05-31
CN1146725A (zh) 1997-04-02
FI963696A0 (fi) 1996-09-18
CZ288150B6 (en) 2001-05-16
NO963971L (no) 1996-11-19
NO314126B1 (no) 2003-02-03
AU2109995A (en) 1995-10-09
NO963971D0 (no) 1996-09-20
EP0751789A1 (en) 1997-01-08
LV12951B (en) 2003-05-20
HU9602583D0 (en) 1996-11-28
JP3560977B2 (ja) 2004-09-02
US6342537B1 (en) 2002-01-29
ATE208212T1 (de) 2001-11-15
AU701872B2 (en) 1999-02-11
US5981605A (en) 1999-11-09
NZ283135A (en) 2004-12-24
CZ272396A3 (en) 1997-06-11
SK119496A3 (en) 1997-06-04
US20020086905A1 (en) 2002-07-04
KR100396278B1 (ko) 2003-11-28
PL179918B1 (pl) 2000-11-30
EP0751789B1 (en) 2001-11-07
DE69523745D1 (de) 2001-12-13
SK281575B6 (sk) 2001-05-10
EE03293B1 (et) 2000-10-16
BR9507164A (pt) 1997-09-09
ES2168111T3 (es) 2002-06-01

Similar Documents

Publication Publication Date Title
UA41989C2 (uk) Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
US4424232A (en) Treatment of herpes simplex
DE59209658D1 (de) Pharmazeutische zusammensetzung zur wund-, narben- und keloidbehandlung
BRPI9908182C1 (pt) composições de proteína de matriz para cura de feridas
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
IS4083A (is) Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja
ES2166783T3 (es) Factor viii activado utilizado como agente terapeutico y metodo para el tratamiento de la deficiencia de factor viii.
DE69613840D1 (de) Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle
DE3856018D1 (de) Verwendung von einer Disaccharidpolysulfat-Aluminium Verbindung zur Herstellung eines Medikaments zur Behandlung von HÄMORRHOIDEN und zur Wundheilung
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
DE69930259D1 (de) Zusammensetzungen zur anwendung von entzündungshemmenden, insbesondere antiseptischen und/oder wundheilenden wirkstoffen im oberen atemwegtrakt und/oder ohr
CA2289717A1 (en) Novel therapy for constipation
BR9809117A (pt) Composição de gel retardado de liberação prolongada, processo de produzir a mesma, formulação farmacêutica,e , processos de tratamento de uma indicação , de uma doença, e de uma inflamação com uma composição de liberação prolongada
CA2411922A1 (en) Composition for pain mediation and apparatus and method of use thereof
DE59600683D1 (de) Verwendung von Trospiumchlorid zur Herstellung eines Arzneimittels zur Behandlung von Blasenkrankheiten
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
BR9406059A (pt) Composição farmacéutica e método para tratamento de uma infecção helmintica em um animal
HK1037980A1 (en) Use of selegiline or desmethylselegiline for the manufacture of a medicament for treating wounds, burns or photodamage.
MX9806188A (es) Derivados de acidos benzofurano-acrilicos y su utilizacion como moduladores de los receptores rxrs o rars.
YU13599A (sh) Primena farmaceutske kompozicije za dobijanje leka u obliku gela
AU749923C (en) The use of combinations of active agents consisting of antimicrobially active substances and plant extracts containing terpene in veterinary medicine
BR9709989A (pt) Processos para tratamento de uma doenca de planta, para preparacão de uma substância ou composicão para tratamento de doenca de planta e para fertilizacão de uma planta, para fertilizacao de uma planta, substâncias ou composicões para tratamento de uma doenca de planta e para fertilizacão de uma planta, e, uso das mesmas.
BR0016646A (pt) Método para tratar um paciente que sofre de dor, e, composição farmacêutica
MXPA01006011A (es) Composicion para tratamiento de quemaduras.
KR960003741A (ko) 조골세포 증식인자